• LAST PRICE
    27.9600
  • TODAY'S CHANGE (%)
    Trending Up0.5100 (1.8579%)
  • Bid / Lots
    16.2200/ 1
  • Ask / Lots
    35.2000/ 1
  • Open / Previous Close
    27.4100 / 27.4500
  • Day Range
    Low 27.0200
    High 28.1200
  • 52 Week Range
    Low 9.8550
    High 32.4500
  • Volume
    309,632
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 27.45
TimeVolumeRAPT
09:32 ET169127.02
09:33 ET409327.38
09:35 ET30027.67
09:42 ET110027.54
09:46 ET30027.58
09:48 ET10027.74
09:50 ET636528
09:51 ET59228
09:53 ET110027.755
09:55 ET10027.7
09:57 ET10027.705
10:02 ET10027.59
10:18 ET300227.91
10:20 ET428727.8
10:22 ET40027.7
10:24 ET20027.68
10:26 ET20027.54
10:29 ET96827.68
10:33 ET37627.63
10:36 ET10027.64
10:38 ET20027.61
10:42 ET93727.5
10:44 ET10027.5
10:47 ET626427.5
10:49 ET201627.69
10:51 ET216327.63
10:56 ET2039527.62
10:58 ET191727.675
11:00 ET90027.72
11:02 ET292927.62
11:07 ET20027.565
11:09 ET40027.5
11:12 ET50027.5
11:14 ET20027.505
11:16 ET438227.56
11:18 ET60027.64
11:20 ET20027.68
11:21 ET93427.79
11:25 ET64127.74
11:30 ET10027.665
11:32 ET10027.71
11:34 ET100427.78
11:36 ET260027.85
11:41 ET10027.94
11:43 ET61527.94
11:45 ET12927.96
11:48 ET10027.905
11:50 ET20027.96
11:52 ET20027.915
11:54 ET30027.87
11:57 ET10027.83
12:01 ET10027.82
12:08 ET20027.78
12:10 ET31527.78
12:12 ET70427.66
12:15 ET70027.76
12:17 ET20027.715
12:19 ET60027.78
12:21 ET40027.85
12:24 ET20027.93
12:28 ET20027.84
12:32 ET10027.785
12:35 ET30027.795
12:37 ET10027.84
12:42 ET120027.71
12:46 ET30027.7
12:48 ET10027.68
12:51 ET60027.63
12:53 ET10027.63
12:55 ET10027.62
12:57 ET10027.615
01:04 ET80027.67
01:08 ET20027.66
01:11 ET10027.65
01:15 ET70027.64
01:18 ET120027.74
01:20 ET30027.83
01:22 ET30027.79
01:24 ET30027.73
01:26 ET10027.68
01:29 ET20027.74
01:31 ET10027.735
01:33 ET40027.755
01:36 ET50027.75
01:38 ET10027.68
01:42 ET230027.82
01:44 ET20027.81
01:45 ET10027.78
01:47 ET40027.75
01:49 ET30027.87
01:51 ET30027.84
01:54 ET30027.82
01:58 ET130127.9
02:00 ET466728.05
02:05 ET20028.01
02:07 ET61228.1
02:09 ET30028.065
02:14 ET10028
02:16 ET100027.97
02:18 ET10027.99
02:20 ET40027.965
02:21 ET33228
02:25 ET30028.025
02:32 ET90027.97
02:34 ET30028
02:36 ET10028.04
02:38 ET40028
02:43 ET10028.025
02:45 ET60028.025
02:48 ET190028.07
02:50 ET50028.09
02:54 ET10028.045
02:56 ET40028.04
03:03 ET10028.025
03:06 ET30028.025
03:08 ET100028.02
03:10 ET10028.04
03:12 ET50028.055
03:14 ET70027.93
03:15 ET45027.905
03:17 ET32027.92
03:19 ET50027.96
03:21 ET10027.99
03:24 ET40028.01
03:26 ET112628
03:30 ET179927.96
03:32 ET10027.96
03:33 ET180027.91
03:35 ET20027.895
03:37 ET110027.845
03:39 ET50027.83
03:42 ET80427.815
03:44 ET176027.84
03:46 ET381627.98
03:48 ET265927.92
03:50 ET314727.92
03:51 ET390527.925
03:53 ET468027.85
03:55 ET599427.72
03:57 ET1699027.875
04:00 ET3385427.96
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRAPT
Rapt Therapeutics Inc
966.0M
-11.0x
---
United StatesIGMS
IGM Biosciences Inc
962.7M
-4.0x
---
United StatesKURA
Kura Oncology Inc
931.1M
-6.7x
---
United StatesJANX
Janux Therapeutics Inc
916.6M
-15.1x
---
United StatesCOGT
Cogent Biosciences Inc
1.0B
-5.8x
---
United StatesARQT
Arcutis Biotherapeutics Inc
1.0B
-2.8x
---
As of 2023-01-29

Company Information

RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in inflammatory diseases and oncology. Utilizing its drug discovery and development engine, the Company develops selective small molecules that are designed to modulate the critical immune responses underlying these diseases. Its two lead drug candidates each target C-C motif chemokine receptor 4 (CCR4). Its inflammation drug candidate, RPT193, is designed to selectively inhibit the migration of type 2 T helper cells (Th2 cells) into inflamed tissues. Its lead oncology drug candidate, FLX475, is designed to selectively inhibit the migration of immunosuppressive regulatory T cells (Treg) into tumors. In addition, RPT193 has clinical translatability in a variety of inflammatory diseases beyond atopic dermatitis (AD), including allergic asthma and chronic rhinosinusitis.

Contact Information

Headquarters
561 Eccles AveSOUTH SAN FRANCISCO, CA, United States 94080-1906
Phone
650-489-9000
Fax
302-531-3150

Executives

President, Chief Executive Officer, Director
Brian Wong
Chief Financial Officer, Principal Accounting Officer
Rodney Young
Chief Human Resource Officer
Gwen Carscadden
Chief Scientific Officer
Dirk Brockstedt
Chief Medical Officer
William Ho

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$966.0M
Revenue (TTM)
$2.3M
Shares Outstanding
34.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.54
Book Value
$6.31
P/E Ratio
-11.0x
Price/Sales (TTM)
423.1
Price/Cash Flow (TTM)
---
Operating Margin
-3,477.79%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.